October 19, 2021 -
Interstitial lung disease, which prominently includes idiopathic pulmonary fibrosis, is a very broad category of chronic lung conditions with considerable nuance. To help break it down within the context of diagnosis and treatment, Dr. Marilyn Glassberg at University of Arizona joins us to discuss the roles of biomarkers, biopsies and drugs. This episode also sheds light on multidisciplinary clinics and stem cell therapy.
Brought to you by the American Lung Association and HCPLive
Tune in and subscribe on:
Have an idea for a future Lungcast episode? Share your idea with us!
